Home
GeneScience Pharmaceuticals

GeneScience Pharmaceuticals Market Share Analysis for July 2026

金赛药业作为一家致力于用科技改善人类生命健康的全球生物药企，金赛药业始终以为医生和患者提供完善的产品和解决方案为己任，围绕儿童健康的多个领域如生长迟缓、超重肥胖、儿童心理、体姿态以及儿童罕见病等现阶段出现的儿童新问题，借助前沿科技打造医疗器械和医疗数据等创新型产品，建立从早筛、监测到干预、治疗的整体解决方案。

Health > Health - Other

Domaingenscigroup.com

Year Founded--

Employees5001 - 10000

Annual Revenue--

GeneScience Pharmaceuticals

GeneScience Pharmaceuticals (including company regionals)

genscigroup.com

See more website traffic and engagement information

Total visits to GeneScience Pharmaceuticals's top domains

Understand GeneScience Pharmaceuticals market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

genscigroup.com31.2K

See more with Sales Intelligence

Avg. visit duration in GeneScience Pharmaceuticals's top domains

Analyze GeneScience Pharmaceuticals engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

genscigroup.com00:07:13

See more with Sales Intelligence

Avg. pageviews on GeneScience Pharmaceuticals's top domains

See how GeneScience Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

genscigroup.com10.29

See more with Sales Intelligence

GeneScience Pharmaceuticals top competitors by domain

Top similar sites in July 2026, ranked by their affinity

endpointclinical.comCompany NameEndpoint ClinicalEmployees501 - 1000HQUnited States, California, San FranciscoAnnual revenue$50M - $75MTotal visits41.8KHealth > Biotechnology and Pharmaceuticals

Top technologies used by GeneScience Pharmaceuticals

These are the website technologies, by industry, used by GeneScience Pharmaceuticals top domains

Advertising (1)

Baidu Ads

Conversion & Analytics (1)

Baidu Analytics

Mobile (1)

Meta Viewport

News & Signals from GeneScience Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsGenscigroup is developing ALK's house dust mite allergy immunotherapy.ALK has announced a partnership agreement with China-based Changchun GeneScience Pharmaceutical to develop and commercialize ALK's house dust mite allergy immunotherapy (AIT) products in Mainland China.